These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 26836702

  • 1. Cyano Group Removal from Cyano-Promoted Aza-Diels-Alder Adducts: Synthesis and Structure-Activity Relationship of Phenanthroindolizidines and Phenanthroquinolizidines.
    Chang CF, Li CF, Tsai CC, Chuang TH.
    Org Lett; 2016 Feb 19; 18(4):638-41. PubMed ID: 26836702
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Concise asymmetric syntheses of novel phenanthroquinolizidines.
    Anton-Torrecillas C, Loza MI, Brea J, Gonzalez-Gomez JC.
    Org Biomol Chem; 2016 Feb 21; 14(7):2264-71. PubMed ID: 26790584
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Synthesis and SAR studies of phenanthroindolizidine and phenanthroquinolizidine alkaloids as potent anti-tumor agents.
    Wang Z, Wu M, Wang Y, Li Z, Wang L, Han G, Chen F, Liu Y, Wang K, Zhang A, Meng L, Wang Q.
    Eur J Med Chem; 2012 May 21; 51():250-8. PubMed ID: 22417638
    [Abstract] [Full Text] [Related]

  • 7. Synthesis of seco-chlorinated derivatives of phenanthroindolizidine precursors via Friedel-Crafts reaction.
    Li S, Han L, Liu J, Hu Y, Zheng D, Fu Y, Huang X.
    Molecules; 2010 Nov 22; 15(11):8501-6. PubMed ID: 21102376
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Asymmetric synthesis of phenanthroindolizidine alkaloids with hydroxyl group at the C14 position and evaluation of their antitumor activities.
    Ikeda T, Yaegashi T, Matsuzaki T, Hashimoto S, Sawada S.
    Bioorg Med Chem Lett; 2011 Jan 01; 21(1):342-5. PubMed ID: 21126872
    [Abstract] [Full Text] [Related]

  • 10. Antitumor agents. 274. A new synthetic strategy for E-ring SAR study of antofine and cryptopleurine analogues.
    Yang X, Shi Q, Bastow KF, Lee KH.
    Org Lett; 2010 Apr 02; 12(7):1416-9. PubMed ID: 20196574
    [Abstract] [Full Text] [Related]

  • 11. Short asymmetric synthesis of phenanthroindolizidines through chiral homoallylic sulfinamines.
    Anton-Torrecillas C, Gonzalez-Gomez JC.
    Org Biomol Chem; 2014 Sep 28; 12(36):7018-25. PubMed ID: 25070561
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Anti-inflammatory effects of 7-methoxycryptopleurine and structure-activity relations of phenanthroindolizidines and phenanthroquinolizidines.
    Yang CW, Chuang TH, Wu PL, Huang WH, Lee SJ.
    Biochem Biophys Res Commun; 2007 Mar 23; 354(4):942-8. PubMed ID: 17274949
    [Abstract] [Full Text] [Related]

  • 14. Recent Advances in Phenanthroindolizidine and Phenanthroquinolizidine Derivatives with Anticancer Activities.
    de Fatima Pereira M, Rochais C, Dallemagne P.
    Anticancer Agents Med Chem; 2015 Mar 23; 15(9):1080-91. PubMed ID: 25991426
    [Abstract] [Full Text] [Related]

  • 15. Synthesis and in vitro antitumor activity of ring C and D-substituted phenanthrolin-7-one derivatives, analogues of the marine pyridoacridine alkaloids ascididemin and meridine.
    Delfourne E, Kiss R, Le Corre L, Dujols F, Bastide J, Collignon F, Lesur B, Frydman A, Darro F.
    Bioorg Med Chem; 2004 Aug 01; 12(15):3987-94. PubMed ID: 15246075
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Synthesis, characterization and biological evaluation of anti-cancer indolizine derivatives via inhibiting β-catenin activity and activating p53.
    Moon SH, Jung Y, Kim SH, Kim I.
    Bioorg Med Chem Lett; 2016 Jan 01; 26(1):110-3. PubMed ID: 26608553
    [Abstract] [Full Text] [Related]

  • 18. Antitumor agents 253. Design, synthesis, and antitumor evaluation of novel 9-substituted phenanthrene-based tylophorine derivatives as potential anticancer agents.
    Wei L, Shi Q, Bastow KF, Brossi A, Morris-Natschke SL, Nakagawa-Goto K, Wu TS, Pan SL, Teng CM, Lee KH.
    J Med Chem; 2007 Jul 26; 50(15):3674-80. PubMed ID: 17585747
    [Abstract] [Full Text] [Related]

  • 19. Simplification of antitumoral phenanthroindolizidine alkaloids: short synthesis of cytotoxic indolizidinone and pyrrolidine analogs.
    Miguélez J, Boto A, Marín R, Díaz M.
    Eur J Med Chem; 2013 Aug 26; 66():540-54. PubMed ID: 23845713
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.